Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Rogers

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Caring : National Association for Home Care Magazine|October 28, 1999
Six steps to smooth OASIS (Outcome Assessment and Information Set) implementationT E Rogers
The American Journal of Medical Technology|July 1, 1976
A modified plate holding system for anaerobic culturesD J Flournoy, T E Rogers
Antimicrobial Agents and Chemotherapy|September 1, 1986
Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoT E Rogers, J N Galgiani
Current Clinical Topics in Infectious Diseases|September 3, 1999
Xanthogranulomatous pyelonephritisC R Gregg, T E Rogers, R S Munford
Antimicrobial Agents and Chemotherapy|October 1, 1979
Assay of serum tobramycin levels with the Bactec 460L E Phillips, R R Martin, L O Gentry, et al.
Texas Medicine|April 1, 1979
Bacteremia caused by Shigella flexneriL E Phillips, T E Rogers, J D Wright, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 6, 2000
Prostaglandins potentiate U-46619-induced pulmonary microvascular dysfunctionJ K Wright, L T Kim, T E Rogers, et al.
Texas Medicine|December 1, 1980
Nonsecretory myeloma: report of a caseW E Luper, L E Phillips, R D Hamill, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1981
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitinL E Phillips, R F Martin, W E Luper, et al.
Shock (Augusta, Ga.)|August 1, 1995
In vitro evidence of neutrophil-mediated lung injury after intestinal reperfusionK M Kadesky, R H Turnage, T E Rogers, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Caring : National Association for Home Care Magazine|October 28, 1999
Six steps to smooth OASIS (Outcome Assessment and Information Set) implementationT E Rogers
The American Journal of Medical Technology|July 1, 1976
A modified plate holding system for anaerobic culturesD J Flournoy, T E Rogers
Antimicrobial Agents and Chemotherapy|September 1, 1986
Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoT E Rogers, J N Galgiani
Current Clinical Topics in Infectious Diseases|September 3, 1999
Xanthogranulomatous pyelonephritisC R Gregg, T E Rogers, R S Munford
Antimicrobial Agents and Chemotherapy|October 1, 1979
Assay of serum tobramycin levels with the Bactec 460L E Phillips, R R Martin, L O Gentry, et al.
Texas Medicine|April 1, 1979
Bacteremia caused by Shigella flexneriL E Phillips, T E Rogers, J D Wright, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 6, 2000
Prostaglandins potentiate U-46619-induced pulmonary microvascular dysfunctionJ K Wright, L T Kim, T E Rogers, et al.
Texas Medicine|December 1, 1980
Nonsecretory myeloma: report of a caseW E Luper, L E Phillips, R D Hamill, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1981
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitinL E Phillips, R F Martin, W E Luper, et al.
Shock (Augusta, Ga.)|August 1, 1995
In vitro evidence of neutrophil-mediated lung injury after intestinal reperfusionK M Kadesky, R H Turnage, T E Rogers, et al.
Pageof 3